Connection

DIMITRIOS LAURIN WAGNER to Cell Line, Tumor

This is a "connection" page, showing publications DIMITRIOS LAURIN WAGNER has written about Cell Line, Tumor.
Connection Strength

0.255
  1. Barring the gates to the battleground: DDR1 promotes immune exclusion in solid tumors. Signal Transduct Target Ther. 2022 01 13; 7(1):17.
    View in: PubMed
    Score: 0.103
  2. Lung tumouroids as a testing platform for precision CAR T cell therapy. Nat Biomed Eng. 2026 Apr; 10(4):815-831.
    View in: PubMed
    Score: 0.034
  3. Personalized CRISPR knock-in cytokine gene therapy to remodel the tumor microenvironment and enhance CAR T cell therapy in solid tumors. Nat Commun. 2025 Dec 09; 16(1):10987.
    View in: PubMed
    Score: 0.034
  4. Central memory phenotype drives success of checkpoint inhibition in combination with CAR T cells. Mol Carcinog. 2020 07; 59(7):724-735.
    View in: PubMed
    Score: 0.023
  5. CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression. Leukemia. 2021 01; 35(1):75-89.
    View in: PubMed
    Score: 0.023
  6. Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells. Cancer Discov. 2017 11; 7(11):1238-1247.
    View in: PubMed
    Score: 0.019
  7. CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies. Blood. 2017 07 20; 130(3):285-296.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.